Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors Hiroyuki KobayashiS. Gail EckhardtMichele L. Basche Original Article 20 May 2005 Pages: 329 - 336
Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin Suzanne M. HessAmanda M. MounceUlrich Bierbach Original Article 13 May 2005 Pages: 337 - 343
Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2) Karin MohrmannMaria A. J. van EijndhovenJan H. M. Schellens Original Article 05 May 2005 Pages: 344 - 350
Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions Lawrence W. AndersonJerry M. CollinsS. Percy Ivy Original Article 13 May 2005 Pages: 351 - 357
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study Periklis PappasVasilis KaravasilisMarios Marselos Original Article 10 May 2005 Pages: 358 - 360
Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer Rene BrunoCarla B. WashingtonPamela Klein Original Article 03 May 2005 Pages: 361 - 369
Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism Milly E. de JongeAlwin D. R. HuitemaSjoerd Rodenhuis Original Article 19 April 2005 Pages: 370 - 378
Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice Ting-Chao ChouYongbiao GuanDale L. Boger Original Article 04 May 2005 Pages: 379 - 390
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss SMF JamiesonJ LiuMJ McKeage Original Article 11 May 2005 Pages: 391 - 399
Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells Jiajun LiuHuiling LuFeng Chen Original Article 19 April 2005 Pages: 400 - 408
Identification of biliary metabolites of ifosfamide using 31P magnetic resonance spectroscopy and mass spectrometry Geoffrey S PayneAndrzej SK Dzik-JuraszMartin O Leach Original Article 05 May 2005 Pages: 409 - 414
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer Francesco BoccardoAlessandra RubagottiDemetrio Del Monaco Original Article 19 April 2005 Pages: 415 - 420
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer Apurva A. DesaiHedy L. KindlerEverett E. Vokes Original Article 13 May 2005 Pages: 421 - 426
Neoadjuvant chemotherapy for epithelial ovarian cancer—role of apoptosis Tania DuttaHimani SharmaNeeta Singh Original Article 19 May 2005 Pages: 427 - 435
Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum Paulo Fernando DiasJarbas Mota Siqueira JrRosa Maria Ribeiro-do-Valle Original Article 18 May 2005 Pages: 436 - 446
